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Objective. To investigate whether the Glycemic Index (GI) or Glycemic Load (GL) of a diet is associated with C-reactive Protein
(CRP) and risk of type 2 diabetes in a prospective study. Materials and Methods. Our analysis included 4,366 participants who
did not have diabetes at baseline. During follow-up 456 diabetes cases were confirmed. Dietary GI and GL were derived from a
food-frequency questionnaire and its association with CRP was examined cross-sectionally using linear regression models. The
association of GI and GL with diabetes incidence was examined using Cox proportional hazard models. Results. GL, but not GI,
was associated with lnCRP at baseline (bGL = 0.11 per 50 units; P = .01). When comparing the highest to the lowest tertile of GI
with respect to diabetes incidence, a Relative Risk (RR) of 0.95 [95%CI 0.75, 1.21] was found after adjustment for lifestyle and
nutritional factors. For GL the RR for diabetes incidence was 1.00 [95%CI 0.74, 1.36]. Additional adjustment for CRP did not
change RRs. Conclusion. Since GI was not associated with CRP and risk of type 2 diabetes, it is unlikely that a high GI diet induces
the previously shown positive association between CRP and risk of type 2 diabetes by increasing CRP concentrations.
1. Introduction
A growing body of evidence suggests a role of low-grade
chronic inflammation in the development of type 2 diabetes.
C-reactive protein (CRP) is a physiological marker of
inflammation and reflects chronic inflammation when the
concentration of this marker is slightly elevated over a longer
period of time [1]. A meta-analysis of 16 prospective cohort
studies showed that CRP was associated with an increased
risk of type 2 diabetes [2]. This risk may be attributed to
central adiposity [2]. It is also suggested that elements of
the diet, like Glycemic Index (GI) and Glycemic Load (GL),
may play a role [3]. The GI expresses the influence of foods
on blood glucose concentrations after consumption [4]. The
GL makes allowance for the GI of a food product and the
portion size eaten [5]. At least four cross-sectional studies
showed a positive association of GI or GL with CRP [6–9].
GI and GL have also been related to an increased risk of type
2 diabetes in several cohort studies [10–14], but not in all
[15–18]. So, GI or GL diets may be of importance in the
development of type 2 diabetes, possibly due to its eﬀect on
CRP concentrations.
We investigated, therefore, whether GI or GL is associated
with CRP and subsequently with risk of type 2 diabetes in
an elderly Dutch population. In this population a positive
association between CRP and risk of type 2 diabetes was
shown previously [19].
2. Materials and Methods
2.1. Study Population. The Rotterdam study is a population-
based prospective cohort study among inhabitants of
Ommoord, a district of the city Rotterdam, The Netherlands
[20]. In 1990 all inhabitants of this district who were aged
≥55 years were invited for participation (n = 10, 215).
Of the 7,983 responders (78%), 2,548 participants did not
provide suﬃcient dietary data, 516 had type 2 diabetes
at baseline, and 553 had not suﬃcient information on
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follow-up time or covariates (Figure 1). Hence, 4,366 par-
ticipants were included in the current analysis. The Medical
Ethics Committee of Erasmus Medical Center, Rotterdam,
The Netherlands, approved the study. All participants gave
informed consent.
2.2. Data Collection
2.2.1. Glycemic Index and Glycemic Load. Dietary assessment
at baseline comprised a self-administered questionnaire
followed by a structured interview with a trained dietician
at the research centre. Participants had to mark the foods
and drinks they had consumed at least twice a month in
the preceding year. Subsequently, the dietician obtained
accurate information on the amount of food eaten using a
semiquantitative food frequency questionnaire [21]. Intake
of food items was converted into total intake of energy
and nutrients using the Dutch Food Composition table
1993 (NEVO). For the intake of fiber we used the Dutch
Food Composition table 1996 (NEVO). Validation of the
questionnaire against 15 multiple-day food records in 80
participants showed a Pearson’s correlation of 0.79 for
adjusted intake of total carbohydrates [21].
To each single food product derived from the question-
naire, GI values were assigned. These values were based on
international published GI tables [22, 23]. Average GI and
GL values for each participant were calculated as follows:
Mean GI =
∑n
i=1
(
GIi × carbohydratesi
)
∑n
i=1
(
carbohydratesi
) ,
Mean GL =
∑n
i=1
(
GIi × carbohydratesi
)
100
.
(1)
GIi is the GI value of food product i. After mean GI
and GL were calculated, mean GI and GL were adjusted for
energy using the residual method [24].
2.2.2. C-Reactive Protein. Nonfasting serum blood samples
were collected at baseline. In the samples, high-sensitivity
CRP was measured using a rate near-infrared particle im-
munoassay (Immage Immuno-chemistry System, Beckman
Coulter, Fullerton, CA). The procedure has been described
in more detail elsewhere [19]. CRP concentrations exceeding
10 mg/L at baseline were excluded from the analysis of CRP,
because these higher concentrations reflect rather acute than
chronic inflammation [1].
2.2.3. Diabetes Incidence. 1990–1993 till 2005. Participants
were considered type 2 diabetes cases when they were regis-
tered by a general practitioner as having type 2 diabetes and
had at least one of the following four criteria: plasma glucose
concentration ≥7.0 mmol/L, random plasma glucose con-
centration ≥11.1 mmol/L, anti diabetes medication, treat-
ment by diet. Diabetes cases were monitored until July 2005.
2.2.4. Nondietary Covariates. General information, for
example, smoking status, education level, family history
10,215 people invited for participation
2,232 people did not respond
7,983 participants were included in the Rotterdam study
between 1990–1993
2,339 without dietary data
209 with unreliable dietary data
516 people were prevalent diabetes cases at baseline
4,919 participants with suﬃcient information on diet and
diabetes incidence
48 with unknown follow-up time
57 without data on covariates
291 without CRP data
157 with CRP concentration >10 mg/L at baseline
4,366 participants included to investigate
Step 2 GI or GL and CRP at baseline
Step 3 GI or GL and risk of type 2 diabetes
273 without data on waist, high-density lipoprotein,
systolic blood pressure, diastolic blood pressure
4,093 participants included to investigate
Step 1 CRP and risk of type 2 diabetes
Figure 1: Flow diagram for selection of participants to investigate
whether glycemic index (GI) or glycemic load (GL) is associated
with C- reactive protein (CRP) and with risk of type 2 diabetes.
of type 2 diabetes, was obtained with a questionnaire at
baseline. A family history of type 2 diabetes was defined
as having a parent, sibling, or both with diabetes onset
between 30 and 65 years. A history of coronary heart diseases
(CHD) was defined as a self-reported myocardial infarction
or angina pectoris with hospital admission. Information on
energy expenditure (kcal/d) was obtained during follow-up
for 3,244 participants of our study population with a physical
activity questionnaire (LASA Physical Activity Question-
naire) [25]. Consequently, energy expenditure could be used
as measure of physical activity in those participants. Infor-
mation on anthropometrics was obtained during a visit at
the research centre at baseline. Waist circumference was mea-
sured at the level midway between the lower rib margin and
the iliac crest with participants in standing position. Blood
pressure was measured twice at the right brachial artery with
a random-zero sphygmomanometer with the participant in a
sitting position. The mean of two consecutive measurements
was used. High density lipoprotein (HDL) was measured
with HDL cholesterol assay (Roche Diagnostics) using
polyethylene glycol-modified enzymes and dextran sulfate.
2.3. Statistical Analysis. Descriptive data were expressed as a
mean (SD), a median (interquartile range), or a percentage.
In order to investigate the eﬀect of GI or GL on the
association between CRP and type 2 diabetes, our analysis
included three steps.
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Table 1: Baseline characteristics of 4,366 Dutch adults aged ≥55 years by tertiles of energy-adjusted glycemic index (GI).1
Low GI (<57.6) Moderate GI (57.6–<60.3) High GI (≥60.3)
(n = 1, 455) (n = 1, 456) (n = 1, 455)
Age (years) 67.3 (7.9) 67.7 (7.7) 66.9 (7.4)
Sex (% male) 26.6 39.7 54.5
Body Mass Index (kg/m2) 26.5 (3.6) 26.2 (3.4) 26.0 (3.8)
C-reactive protein (mg/L)2 1.6 (0.80–2.9) 1.7 (0.83–3.0) 1.7 (0.83–3.1)
Anti-inflammatory medication (%) 8.0 6.6 7.7
Family history of diabetes (%) 26.5 26.8 29.7
History of CHD (%) 10.0 11.9 13.4
Smoking (% current) 15.8 20.4 32.0
Education level (% low) 33.6 33.5 35.7
Dietary intake
Total energy (kcal/d) 1967 (555) 2005 (491) 1971 (464)
Carbohydrate (en%) 44.2 (6.6) 44.7 (6.6) 43.7 (7.6)
Mono- and disacharides (en%) 24.5 (5.7) 22.6 (5.5) 19.7 (6.5)
Polysacharides (en%) 19.7 (3.7) 22.0 (3.7) 23.7 (4.4)
Energy-adjusted glycemic load 119 (19.0) 128 (20.1) 133 (23.1)
Fiber (g/d) 27.1 (8.3) 26.3 (6.4) 25.1 (6.6)
Protein (en%) 18.0 (3.3) 16.7 (2.8) 16.2 (2.8)
Fat (en%) 35.9 (6.3) 36.5 (6.1) 37.3 (6.2)
Saturated fatty acids (en%) 14.3 (3.4) 14.4 (3.1) 14.6 (3.1)
Mono-unsaturated fatty acids (en%) 12.3 (2.7) 12.3 (2.7) 12.6 (2.8)
Poly-unsaturated fatty acids (en%) 6.5 (2.8) 7.0 (2.8) 7.3 (2.9)
Alcohol drinkers (%) 79.2 82.2 79.9
Alcohol (g/d)2,3 6.0 (1.3–15.7) 6.4 (1.4–16.3) 8.7 (1.8–21.8)
1
Means (SD) or percentages unless otherwise indicated.
2Values are expressed as median (interquartile range), because of their skewed distribution.
3Only in alcohol drinkers.
Step 1. The positive association between CRP and risk of
type 2 diabetes, as shown previously in the Rotterdam Study
(n = 5, 901) [19], was verified in our subpopulation of the
same study (n = 4, 093) (Figure 1).
Step 2. Linear regression models were used with energy-
adjusted GI or GL as independent variable and CRP
at baseline as dependent variable. CRP was transformed
logarithmically to achieve a normal distribution. In addition
to energy-adjusted GI or GL, model 1 included age (years),
sex, smoking (current, former, never), and family history of
diabetes (yes, no) as covariates. Model 2 was similar to model
1 with additional adjustment for intake of five dietary factors:
energy (kcal/d), protein (energy-%), saturated fat (energy-
%), alcohol (0, >0–10, >10–20, >20 g/d), and fiber (g/d).
Model 3 was similar to model 2 with additional adjustment
for BMI (kg/m2).
Step 3. We explored the association between energy-adjusted
GI or GL and risk of type 2 diabetes using Cox proportional
hazard models. Hazard Ratios (RR) and 95% CI provided
by these Cox models expressed the risk relative to the
lowest tertile. Model 1, model 2, and model 3 included the
same covariates as used in Step 2. To investigate a potential
intermediate eﬀect of CRP within the association of GI or
GL with type 2 diabetes, an additional model was used. This
model was similar to model 3 with additional adjustment for
baseline lnCRP concentration.
In Steps 1 and 3, we modeled the median value of
each tertile of GI or GL as continuous variable to test for
linear trends across categories. To investigate potential eﬀect
measure modification, the association between GI and GL
and risk of type 2 diabetes was studied separately for men
and women and for participants with a low and high BMI
(median split: ≤25.9 versus >25.9 kg/m2, resp.).
Analyses were carried out using the statistical software
program SAS version 9.1. A two-sided P value less than .05
was considered as statistically significant for all analysis.
3. Results
At baseline, the mean of GI was 59 (SD 3) and mean GL was
127 (SD 22). The highest tertile of GI included more smokers
and more men than the lowest tertile (Table 1). Intake
of polysacharides increased, whereas intake of mono- and
disaccharides and fiber decreased across tertiles of GI. Using
stepwise regression, the main contributors to the variation
in energy-adjusted GL appeared to be sweets (26%), fats
(9%), bread (9%), alcoholic drinks (7%), and nuts (5%).
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The main contributors to the variation in energy-adjusted
GI were milk products (28%), fruit (20%), bread (13%),
potatoes (5%), and cakes (2%). Median CRP concentration
was 1.65 mg/L, and 1,097 (25%) participants had an elevated
CRP level (>3 mg/L) at baseline.
Step 1 of our analysis included 4,093 participants of
whom 423 developed type 2 diabetes during a median
follow-up time of 11.0 years. The analysis confirmed that
CRP at baseline was associated with an increased risk of
type 2 diabetes after adjustment for age, sex, BMI, waist,
systolic blood pressure, diastolic blood pressure, and HDL
(RRCRP Q4 versus Q1: 1.76 (95%CI 1.27, 2.45); Ptrend < .01).
This RR was in line with RRs found when adjusted addi-
tionally for GI or GL (RRCRP Q4 versus Q1: 1.76 (95%CI 1.27,
2.43); RRCRP Q4 versus Q1: 1.76 (95%CI 1.27, 2.44), resp.). The
association did not diﬀer considerably between participants
with a low or high GI diet (Pinteraction = .53) and between
participants with a low or high GL diet (Pinteraction = .99).
Step 2 of our analysis showed that after adjustment for
lifestyle factors, nutritional factors, and BMI, a 50 unit
increase in GL was associated with a 12% higher CRP
concentration at baseline (P = .01) (Table 2). No association
was observed for a 10 unit increase in GI (b = 0, P = .90).
Step 3 of our analysis included 4,366 participants whose
median follow-up was 12.4 years. A number of 456 par-
ticipants developed type 2 diabetes. When comparing the
highest to the lowest tertile in this population, an adjusted
RR of 0.95 (95%CI 0.75, 1.21) was found for GI (model 3)
(Table 3). For GL this adjusted RRT3 versus T1 was 1.00 (95%CI
0.74, 1.36). So, GI and GL were not associated with the
risk of type 2 diabetes in this study. The RR found for
GL was comparable with the one found for the association
between intake of total carbohydrates and risk of type 2
diabetes (Model 3 RRQ4 versus Q1: 1.04 (95%CI 0.71, 1.53)).
The similar results also reflect the high correlation between
total carbohydrates and GL (r = 0.93). After adding CRP
at baseline to model 3, RRs for risk of type 2 diabetes did
not change considerably (RRGI T3 versus T1 : 0.96 (95%CI 0.75,
1.22); RRGL T3 versus T1 : 0.99 (95%CI 0.73, 1.35)) (Table 3).
In those with available information on physical activity,
additional adjustment for energy expenditure did not change
the RRs considerably (data not shown).
The association between GI or GL and risk of type 2
diabetes did not diﬀer considerably between men and women
(Model 3: Pinteraction GI = .75; Pinteraction GL = .08) and
between participants with a low and high BMI (Model 3:
Pinteraction GI = .32; Pinteraction GL = .29). Exclusion of partici-
pants with CHD at baseline (n = 514) did not substantially
change the results (Model 3 RRGI T3 versus T1 : 0.93 (95%CI
0.72, 1.21); RRGL T3 versus T1 : 1.03 (95%CI 0.74, 1.43)).
4. Discussion
In this Dutch population, GL was associated positively with
CRP at baseline, but not with risk of type 2 diabetes. GI was
not associated with CRP nor with risk of type 2 diabetes.
A high GI diet, therefore, could not explain the positive
association between CRP and risk of type 2 diabetes by
increasing CRP concentrations.
Table 2: Beta coeﬃcients (SEE) for the association of energy-
adjusted glycemic index (GI) or glycemic load (GL) with ln-C-
reactive protein (CRP) in Dutch adults aged ≥55 years.
Ln-CRP at baseline
n = 4, 366
GI per 10 units GL per 50 units
Crude model 0.11 (0.04), P < .01 −0.04 (0.03), P = .25
Model 1 0.04 (0.04), P = .31 −0.03 (0.03), P = .41
Model 2 0.05 (0.04), P = .29 0.09 (0.05), P = .05
Model 3 0.005 (0.04), P = .90 0.11 (0.04), P = .01
Values are beta-coeﬃcients with SEE.
Model 1: adjusted for age, sex, smoking, and family history of diabetes.
Model 2: as model 1 with additional adjustments for intake of energy,
protein, saturated fat, alcohol, and fiber.
Model 3: as model 2 with additional adjustment for BMI.
We were able to study how GI and GL were associated
with CRP and type 2 diabetes in a prospective cohort study
with a high response rate, with a long follow-up period, with
confirmed diabetes cases, and with available information on
CRP concentration at baseline of a large population.
Our FFQ measured adequately intake of carbohydrates,
which was correlated highly with GL, but was not designed to
measure GI or GL. It could be, therefore, that food products
with a very high or low GI were not taken into account. This
might explain the small range in GI and GL in our study. A
comparable range in GI, however, was also observed in other
Dutch cohorts in whom another FFQ was used [8, 26]. In one
of the cohorts even a smaller range was found when GI was
based on twelve 24-hr recalls instead of on a FFQ [26]. This
shows that a small range in GI may exist in the Netherlands.
National data on GI values of Dutch food products, however,
would have provided more accurate measure of GI.
GL, but not GI, was associated positively with CRP at
baseline in this study. Due to the high correlation between
GL and intake of carbohydrates in our population, the eﬀect
of GL itself could not be separated from the eﬀect of total car-
bohydrate intake. Other cross-sectional studies on the asso-
ciation with CRP observed either positive associations for
high GL diet [6] or high GI diet [7–9] or no association for
GI [6, 27–29] or GL [7–9, 28–30]. No associations were also
observed between changes in GI or GL and changes in CRP
in a longitudinal study with a one-year follow-up [27]. On
the contrary, one randomized trial in participants with type
2 diabetes showed that reduction in CRP concentration after
1 year was more pronounced in a low GI diet than a high GI
diet [31]. Other randomized trials with a shorter duration,
however, did not observe diﬀerential eﬀects on CRP between
a low GI diet and a high GI diet independently of weight
lost [32–37]. Taking these results together, it is not very likely
that GI aﬀects CRP concentrations. The high within person
variation in CRP, however, could have reduced the power of
the statistical tests of the beta-coeﬃcient [38, 39]. Therefore,
duplicate measures of CRP should be used in new studies.
Our findings concerning the association of GI or GL with
risk of type 2 diabetes are not in line with the conclusion of
a meta-analysis published in 2008 [10]. This meta-analysis
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Table 3: Relative risks (95%CI) for incident type 2 diabetes by tertiles of energy-adjusted glycemic index and glycemic load in 4,366 Dutch
adults aged ≥55 years.
Low Moderate High P for trend
Glycemic index (<57.6) (≥57.6–<60.3) (≥60.3)
Median 55.7 58.9 62.1
# cases/total 149/1,455 141/1,456 166/1,455
Person years 16,227 16,023 15,691
Crude model 1 0.96 (0.76, 1.21) 1.16 (0.93, 1.44) .19
Model 1 1 0.91 (0.72, 1.15) 1.02 (0.81, 1.29) .84
Model 2 1 0.96 (0.76, 1.22) 1.06 (0.83, 1.35) .64
Model 3 1 0.94 (0.74, 1.19) 0.95 (0.75, 1.21) .71
Model 4 1 0.92 (0.73, 1.17) 0.96 (0.75, 1.22) .75
Glycemic load (<117.6) (≥117.6–<134.6) (≥134.6)
Median 107.1 126.4 146.1
# cases/total 173/1,455 149/1,456 134/1,455
Person years 15,825 16,206 15,910
Crude model 1 0.83 (0.67, 1.03) 0.77 (0.61, 0.96) .02
Model 1 1 0.86 (0.69, 1.07) 0.77 (0.61, 0.96) .02
Model 2 1 0.92 (0.72, 1.17) 0.98 (0.72, 1.33) .86
Model 3 1 0.91 (0.71, 1.16) 1.00 (0.74, 1.36) .96
Model 4 1 0.90 (0.70, 1.15) 0.99 (0.73, 1.35) .91
Model 1: adjusted for age, sex, smoking, and family history of diabetes.
Model 2: as model 1 with additional adjustments for intake of energy, protein, saturated fat, alcohol, and fiber.
Model 3: as model 2 with additional adjustment for BMI.
Model 4: as model 3 with additional adjustment for ln C-reactive protein.
on five cohort studies showed that high GI or GL diets were
associated with an increased risk of type 2 diabetes (RRGI
1.40 (95%CI 1.23, 1.59); RRGL 1.27 (95%CI 1.12, 1.45)).
After this meta-analysis, these associations were investigated
additionally in eight cohort studies. These studies found
associations of GI with risk of type 2 diabetes ranging from a
6% lower risk to a 50% higher risk [11, 13–18]; with two of
them statistically significant [11, 13]. The associations of GL
with risk of type 2 diabetes ranged from a 20% lower risk
to a 41% higher risk [11–17]. Three studies reported that
their findings were statistically significant in women [12, 13]
or in both sexes [14]. Four of these newly published studies
[12–15] and our study met the inclusion criteria used in the
meta-analysis by Barclay et al. [10]. Since ranges in GI do
not always overlap among studies, a new pooled risk estimate
would be diﬃcult to interpret. Studies with high GI values
(median of lowest category >63) observed higher risks of
type 2 diabetes [5, 40, 41], whereas studies with low GI values
(median of highest category <63) did not observe associa-
tions with type 2 diabetes [14, 15]. Our study gives additional
information about the association between lower ranges of
GI values and risk of type 2 diabetes, which was lacking in
the meta-analysis. Overall, this might suggest that only high
GI values are associated adversely with risk of type 2 diabetes.
5. Conclusion
Both GI and GL were not associated with risk of type 2
diabetes, although GL was associated positively with CRP
concentrations. It is, therefore, unlikely that a high GI diet
induces the positive association between CRP and risk of
type 2 diabetes by increasing CRP concentrations.
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